$NINE

Nine Energy Service (NINE) Reports Q1 Loss, Tops Revenue Estimates

Nine Energy (NINE) delivered earnings and revenue surprises of -20% and 0.92%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Original reporting
Zacks Commentary · Zacks Equity Research
Published May 8, 2025, 12:10 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 8, 2025, 2:31 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Nine Energy Service (NINE) Reports Q1 Loss, Tops Revenue Estimates — source image
Decision brief

The 30-second read

$NINEBearishMed
01

Why it matters

The earnings miss could lead to short-term selling pressure, but the slight revenue beat and neutral sentiment suggest limited long-term impact unless further negative news emerges.

02

Market read

The news is relevant primarily to traders and investors focused on the energy services sector, with limited broader market impact.

03

What to watch

Potential for operational improvements or sector-wide recovery that could mitigate short-term declines.

Timing: Immediate, as earnings are recent

Background

Nine Energy Service operates in the energy sector, providing hydraulic fracturing and well site services. Recent earnings results show a mixed picture with a notable loss but slight revenue growth.

Company-level read

Ticker impact

$NINEBearishMedium confidence
Context

Primary focus due to recent earnings report

Expected impact

Potential short-term decline of 5-10%

Evidence & confidence

Earnings miss and negative sentiment suggest near-term weakness, but slight revenue beat and neutral sentiment limit downside risk.

Market effects

The energy services sector may experience increased volatility, especially among companies with similar exposure

Limited, primarily affecting US-based energy companies

Minimal, as the impact is sector-specific and localized

Counterpoint

The stock may have already priced in the earnings miss, and a rebound could occur if market sentiment improves or if company guidance remains positive.

Key entities

  • Nine Energy Service

    An energy services company specializing in hydraulic fracturing.

Related articles

$NINEMedAI 8/10

Nine Energy Service (NINE) Q2 2026 Earnings Call Transcript

Nine Energy Service (NINE) reported Q2 2026 revenue of $141.8 million, within guidance, but adjusted EBITDA of $8.6 million below guidance due to margin compression and cost inflation in coiled tubing. Net loss was $4.9 million ($0.35/diluted share). Liquidity was $46.8 million; Q3 revenue guidance is $133 million to $143 million.

$NINEMed

Nine Energy Service Q2 Earnings Call Highlights

Nine Energy Service (NINE) discussed Q2 results and coiled tubing outages during its earnings call. Coiled Tubing units affected were described as unusual, with limited excess market capacity. Completion Tools revenue rose about 44% to $37.1M. Cementing revenue rose 3% to $55.3M; wireline fell 4% to $23M. Q3 revenue guidance was $133M to $143M.

$NINEMed

Nine Energy Service, Inc. (NINE): Results of Operations and Financial Condition

Nine Energy Service, Inc. (NINE) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Nine Energy Service Announces Second Quarter 2026 Results ● Revenue, net loss and adjusted EBITDA A of $141.8 million, $(4.9) million and $8.6 million, respectively, for the second quarter of 2026 ● Total liquidity as of June 30, 2026 of $46.8 million HOUSTON – Nine

$BNTXMed

BioNTech Ended a Cancer Vaccine Trial. What Does it Mean for its mRNA Strategy?

BioNTech (NASDAQ:BNTX) halted a mid-stage trial of its mRNA cancer vaccine, autogene cevumeran, due to an overall survival imbalance. The decision raises concerns about its mRNA strategy in colorectal cancer and other 'cold' tumors. BioNTech plans to continue other trials, including one for pancreatic cancer and BNT113 for head and neck cancer. The company also focuses on diversifying its oncology pipeline. According to Reuters, the news caused a 7.5% drop in BioNTech's US-listed shares.

$VOW3.DEMed

HISTORIC TURN: Volkswagen To Produce Components For Israel’s Iron Dome System In Germany

Volkswagen (VW) plans to produce components for Israel's Iron Dome missile defense system at its Osnabrück, Germany factory. The move is part of VW's restructuring efforts amid economic challenges and competition. The project involves a joint venture with Israeli defense company Rafael and the German state of Lower Saxony, aiming to overcome opposition from Qatar's sovereign wealth fund, a VW stakeholder. This marks VW's return to defense-related manufacturing as European defense spending rises.

$XOMMed

Piper Sandles Sees ExxonMobil (XOM) Heading Toward New Highs

Piper Sandler raised its price target for ExxonMobil (XOM) to $185, citing strong fundamentals, cost savings, and growth in Guyana. XOM's Q2 earnings beat expectations, with high free cash flow and shareholder returns. However, risks include exposure to Middle East conflicts and potential crude price normalization. XOM's stock has risen 30% in 2026, with a 16% upside implied by the new target.